Vanderbilt Health lands three of 35 Susan G. Komen research grants
Department of Medicine faculty Tuya Pal, MD, and Ben Ho Park, MD, PhD, were among those awarded grants by Susan G. Komen, the internationally known nonprofit breast cancer organization.
Johnson among those 'transforming the Cancer Center'
Douglas Johnson, MD, MSCI, professor of Medicine, has been named associate director for Translational Research.
New research: Heart drug may also limit the spread of cancer
Early clinical research by Vanderbilt Health and Cumberland Pharmaceuticals Inc. suggests that an investigational drug originally developed to treat cardiovascular disease may reduce the risk of metastasis — or spread — of breast, lung and other solid tumors.
Liquid biopsy predicts response to breast cancer immunotherapy
This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers, including Justin Balko, PhD, PharmD, reported April 22 in the journal Science Translational Medicine.
Genomic testing finds a higher prevalence of high-risk breast cancer in Black women
The findings were reported March 19 in the Nature partner journal npj Breast Cancer; the paper’s corresponding author is Sonya Reid, MD, MPH, associate professor of Medicine at Vanderbilt Health.
How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery
Mohamed Shanshal, MD, and Fabien Maldonado, MD, faculty members in the Department of Medicine, were integral members of the treatment team.
Patient with melanoma receives tumor-infiltrating lymphocyte therapy
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person’s natural defense system against tumors.
Guide published for outpatient cancer treatment with bispecific antibodies
Hematologists with Vanderbilt-Ingram Cancer Center have published strategies for implementing outpatient treatment programs for bispecific antibodies, an immunotherapy that can cause adverse reactions.
Park announced as recipient of 2025 AACR Distinguished Lectureship in Breast Cancer Research award
Ben Ho Park, MD, PhD, Professor of Medicine (Hematology and Oncology) and Director of the Vanderbilt-Ingram Cancer Center, was recently announced as the recipient of the American Association for Cancer Research's 2025 Distinguished Lectureship in Breast Cancer Research award.